TABLE 2

Pharmacokinetic parameters of GLB after oral administration (10 mg/kg) to CON, DM, and DM+IN rats

Data represent the mean ± S.D. for six or seven rats.

ParameterCONDMDM+IN
AUC0–∞, μg-h/ml2.61 ± 0.4415.23 ± 4.79**3.00 ± 1.41##
AUC0–t, μg-h/ml2.35 ± 0.2913.27 ± 3.94**2.38 ± 0.96##
t1/2, h4.55 ± 1.235.11 ± 1.088.18 ± 6.43
Mean residence time, h7.23 ± 1.709.28 ± 1.578.15 ± 2.30
CL/F, l · h−1 · kg−13.93 ± 0.680.72 ± 0.26**3.98 ± 1.76##
Vd/F, l/kg25.72 ± 8.846.36 ± 0.63**36.8 ± 17.10##
Cmax, μg/ml0.35 ± 0.111.25 ± 0.24**0.25 ± 0.06##
Time to reach Cmax, h1.50 ± 1.007.2 ± 1.79**1.0 ± 0.61##
Biliary excretion, % of dose0.01 ± 0.0070.097 ± 0.1300.018 ± 0.017
Urinary excretion, % of dose0.0042 ± 0.0010.023 ± 0.009**0.019 ± 0.005##
Fecal excretion, % of dose72 ± 1040 ± 9**50 ± 21#
  • ** p < 0.01, versus CON rats;

  • # p < 0.05,

  • ## p < 0.01, versus DM rats.